The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

Globe Investor

News Sources

Take control of your investments with the latest investing news and analysis

Press release from Business Wire

Sanofi FY 2012 - Interview with CEO Chris Viehbacher

Thursday, February 07, 2013

Sanofi FY 2012 - Interview with CEO Chris Viehbacher01:45 EST Thursday, February 07, 2013 PARIS (Business Wire) -- Sanofi, a global and diversified healthcare leader, reports 2012 results. CEO Chris Viehbacher comments on 2012 results and outlook for 2013. Click to watch the video: http://bit.ly/XkZjhU Topics covered in the interview include: - 2012 Results- Genzyme- Emerging Markets- Diabetes franchise- R&D Pipeline- Animal Health- Capital Allocation- Cost savings- 2013 Guidance About Sanofi Sanofi, a global and diversified healthcare leader, discovers, develops and distributes therapeutic solutions focused on patients' needs. Sanofi has core strengths in the field of healthcare with seven growth platforms: diabetes solutions, human vaccines, innovative drugs, consumer healthcare, emerging markets, animal health and the new Genzyme. Sanofi is listed in Paris (EURONEXT: SAN) and in New York (NYSE: SNY). Company website: www.sanofi.com SanofiInvestor Relations:Sébastien Martel, +33 1 53 77 45 45IR@sanofi.comorMedia Relations:+33 1 53 77 45 02MR@sanofi.com